Tea and flavonoids: Where we are, where to go next1-5

American Journal of Clinical Nutrition

Volumn 98, Issue 6, 2013, Pages

  Dwyer, Johanna T ^a   Peterson, Julia ^b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGLYCONE; ANTHOCYANIN; APIGENIN; BIOLOGICAL MARKER; CATECHIN; CHROMAN DERIVATIVE; CYANIDIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN GALLATE; FLAVAN DERIVATIVE; FLAVANONE; FLAVANONE DERIVATIVE; FLAVONE; FLAVONOID; FLAVONOL; GENISTEIN; ISOFLAVONE; NARINGENIN; NITROUS OXIDE; PLANT GLYCOSIDE; PLANT MEDICINAL PRODUCT; PROANTHOCYANIDIN; PROCYANIDIN B1; PROCYANIDIN DERIVATIVE; QUERCETIN; TANNIN DERIVATIVE; THEAFLAVIN; THEARUBIGIN DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHEMICAL COMPOSITION; CORONARY ARTERY DISEASE; DIET; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG EFFICACY; DRUG METABOLISM; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FOOD; HEALTH; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK REDUCTION; TEA;

ANIMALS; CAMELLIA SINENSIS; CARDIOVASCULAR DISEASES; DRUG LABELING; EVIDENCE-BASED MEDICINE; FLAVONOIDS; HEALTH; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; TEA;

EID: 84888243898     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.113.059584     Document Type: Article

References (44)

1. Scalbert A, Andres-Lacueva C, Arita M, Kroon P, Manach C, Urpi- Sarda M, Wishart D. Databases on food phytochemicals and their health-promoting effects. J Agric Food Chem 2011;59:4331-48
2. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50
3. Peterson JJ, Dwyer JT, Jacques PF, McCullough ML. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev 2012;70:491-508
4. McCullough ML, Peterson JJ, Patel R, Jacques PL, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012;95:454-64
5. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895-909
6. Cassidy A, O'Reilly ÉJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr 2011;93:338-47
7. Jennings A, Welch AA, Fairweather-Tait SJ, Kay C, Minihane AM, Chowienczyk P, Jiang B, Cecelja M, Spector T, Macgregor A, et al. Higher anthocyanin intake is associated with lower arterial stiffness and central blood pressure in women. Am J Clin Nutr 2012;96:781-8
8. Ellinger S, Reusch A, Stehle P, Helfrich HP. Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am J Clin Nutr 2012;95:1365-77
9. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart EE, Ding EL. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short term studies. J Nutr 2011;141:1982-8
10. Tokede OA, Gaziano JM, Djousse L. Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr 2011;65:879-86
11. Zomer E, Owen A, Magliano DJ, Liew D, Reid CM. The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model. BMJ 2012;344:e3657
12. Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003;133(suppl):3248S-54S
13. Peterson J, Dwyer J, Bhagwat S, Haytowitz D, Holden J, Eldridge AL, Beecher G, Aladesnmi J. Major flavonoids in dry tea. J Food Comp Anal 2005;18:487-501
14. Serrano J, Puupponen-Pimiä R, Dauer A, Aura AM, Saura-Calixto F. Tannins: current knowledge of food sources, intake, bioavailability and biological effects. Mol Nutr Food Res 2009;53:S310-29
15. Peterson J, Dwyer J, Jacques P, Rand W, Prior R, Chui K. Tea variety and brewing techniques influence flavonoid content of black tea. J Food Comp Anal 2004;17:397-405
16. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 2009;40:1786-92
17. Ruxton CHS, Mason P. Is black tea consumption associated with a lower risk of cardiovascular disease and type 2 diabetes? Nutr Bull 2012;37:4-15
18. Hartley L, Flowers N, Clarke A, Stranges S, Hooper L, Rees K. Green and black tea for primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2012 i(6) Art. No: CD009934
19. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D,Woodward M. Coffee, decaffeinated coffee and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009;169:2053-63
20. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine and risk of type 2 diabetes: a prospective cohort study in younger and middle aged U.S. women. Diabetes Care 2006;29:398-403
21. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Miliazzo S, Horneber M. Green tea for the prevention of cancer. Cochrane Database Syst Rev 2009;3:CD005004
22. Gallagher AM, Meijer GW, Richardson DP, Rondeu R, Skarp M, Stasse- Wolthuis M, Tweedie GC,Witkamp R. A standardised approach towards PROving the efficacy of foods and food constitutents for health CLAIMs (PROCLAIM): providing guidance. Br J Nutr 2011;106:S16-28
23. Verhagen H, Vos E, Francl S, Heinonen M, van Loveren H. Status of nutrition and health claims in Europe. Arch Biochem Biophys 2010;501:6-15
24. US Food and Drug Administration. Claims that can be made for conventional foods and dietary supplements. September 2003. Available from: http://www.fda.gov/food/labelingnutrition/labelclaims/ucm111447.htm (cited 23 January 2013)
25. Aggett PJ, Hathcock J, Jukes D, Richardson DP, Calder PC, Bischoff- Ferrari H, Nicklas T, Mühlebach S, Kwon O, Lewis J, et al. Nutrition issues in Codex: health claims, nutrient reference values and WTO agreements: a conference report. Eur J Nutr 2012;51:S1-7
26. Ottaviani JI, Kwik-Uribe C, Keen CL, Schroeter H. Intake of dietary procyanidins do not contribute to the pool of circulating flavanols in humans. Am J Clin Nutr 2012;95:851-8
27. Queipo-Ortuño MI, Boto-Ordóñez M, Murri M, Gomez-Zumaquero JM, Clemente-Postigo M, Estruch R, Cardona Diaz F, Andrés-Lacueva C, Tinahones FJ. Influence of red wine polyphonols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr 2012; 95:1323-34
28. Sun J, Chen P, Lin LZ, Harnly JM. A non-targeted approach to chemical discrimination between green tea dietary supplements and green tea leaves by HPLC/MS. J AOAC Int 2011;94:487-97
29. Egert S, Rimbach G. Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr 2011;2:8-14
30. Sarma DN, BarrettML, Chavez ML, Gardiner P, Ko R,Mahady GB, Marles RJ, Pellicore LS, Giancaspro GI, Low Dog T. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008;31:469-84
31. Otera H, Tada K, Sakurai T, Hashimoto K, Ikeda A. Hypersensitivity pneumonitis associated with inhalation of catechin-rich green tea extracts. Respiration 2011;82:388-92
32. Verhelst X, Burvenich P, Van Sassenbroeck D, Gabrial C, Lootens M, Baert D. Acute hepatitis after treatment for hair loss with oral greentea extracts (Camellia Sinensis). Acta Gastroenterol Belg 2009;72: 262-4
33. Masterjohn C, Bruno RS. Theraperutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev 2012;70:41-56
34. Zhang Y, Cao J, Chen W, Yang J, Hao D, Zhang Y, Chang P, Zhao X. Reproducibility and relative validity of a food frequency questionnaire to assess intake of dietary flavonol and flavone in Chinese university campus population. Nutr Res 2010;30:520-6
35. Zhang Y, Li Y, Cao C, Cao J, Chen W, Zhang Y, Wang C, Wang J, Zhang X, Zhao X. Dietary flavonol and flavone intakes and their major food sources in Chinese adults. Nutr Cancer 2010;62:1120-7
36. Pérez-Jiménez J, Hubert J, Hooper L, Cassidy A, Manach C,Williamson G, Scalbert A. Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr 2010;92:801-9
37. Mack A, Balogh E, Micheel C. Perspectives on biomarker and surrogate endpoint evaluation: discussion forum summary. Washington, DC: National Academies Press, 2011
38. European Food Safety Administration Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins from green tea, and contribution to the maintenance or achievement of a normal body weight (ID 1107, 1112, 1544, 2716), increased beta-oxidation of fatty acids leading to a reduction in body fat mass (ID 1123, 1124, 3698), and maintenance of normal blood glucose concentrations (ID 1115, 1545) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. European Food Safety Agency Journal 2010;8:1791. DOI:10.2903/j.efsa.2010.1791
39. European Food Safety Administration Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins in green tea, and improvement of endotheliumdependent vasodilation (ID 1106, 1310), maintenance of normal blood pressure (ID 1310, 2657), maintenance of normal blood glucose concentrations (ID1108), maintenance of normal blood LDL-cholesterol concentrations (ID2640), protection of the skin from UV induced (including photo-oxidative) damage (ID 1110,1119), protection of DNA from oxidative damage (ID 1120,1121), protection of lipids form oxidative damage (ID 1275), contribution to normal cognitive function (ID 1117, 2812), "cardiovascular system" (ID 2814), "invigoration of the body" (ID 1274, 3280), decreasing potentially pathogenic gastrointestinal microorganisms (ID 1118), "immune health" (ID 1273) and "mouth" (ID 2813) pursuant to Article 13 (1) of Regulation (EC) No 1924/2006. European Food Safety Agency Journal 2011;9:2055. DOI: 10.2903/j.efsa.2011.2055.
40. European Food Safety Administration Panel on Dietetic Products. Scientific opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins in green tea and tannins in black tea, protection of DNA, proteins and lipids from oxidative damage (ID1103,1276,1311,1708,2664), reduction of acid production in dental plaque (ID1105, 1111), maintenance of bone (ID1109), decreasing potentially pathogenic intestinal microorganisms (ID1116), maintenance of vision (ID 1280), maintenance of normal blood pressure (ID1546), and maintenance of normal blood cholesterol concentrations (ID1113, 1114) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. European Food Safety Authority Journal 2010;8: 1463. DOI:10.2903/j.efsa.2010.1463
41. European Food Safety Administration Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific opinion on the substantiation of health claims related to L-theanine from Camellia sinensis (L.) Kuntze (tea) and improvement of cognitive function (ID 1104, 1222, 1600, 1601, 1707, 1935, 2004, 2005), alleviation of psychological stress (ID 1598,1601), maintenance of normal sleep (ID 1222, 1737,2004), and reduction of menstrual discomfort (ID 1599) pursuant to Article 13(1) of Regulation (EC) No 1924-2006. European Food Safety Agency Journal 2011;9:2338. DOI:10.2903/j.efsa.2011.2238
42. Procházková D, Bouš ová I,Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011;82:513-23
43. Finley JW, Kong AN, Hintze KJ, Jeffery EH, Ji LL, Lei XG. Antioxidants in foods: state of the science important to the food industry. J Agric Food Chem 2011;59:6837-46
44. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, Serafini M, Scalbert A, Sies H, Vidry S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 2011;141(suppl):989S-1009S